Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities
Hurst DR, Schwartz MA, Ghaffari MA, Jin YH, Tschesche H, Fields GB, Sang QXA (2004)
BIOCHEMICAL JOURNAL 377: 775-779.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Hurst, DR;
Schwartz, MA;
Ghaffari, MA;
Jin, YH;
Tschesche, HaraldUniBi;
Fields, GB;
Sang, QXA
Einrichtung
Abstract / Bemerkung
Membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) is a major collagenolytic enzyme that plays a vital role in development and morphogenesis. To elucidate further the structure-function relationship between the human MT1-MMP active site and the influence of the haemopexin domain on catalysis, substrate specificity and inhibition kinetics of the cdMT1-MMP (catalytic domain of MT1-MMP) and the ecto domain DeltaTM-MT1-MMP (transmembrane-domain-deleted MT1-MMP) were compared. For substrate 1 [Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, where Mca stands for (7-methoxycoumarin-4-yl)acetyl- and Dpa for N-3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl], the activation energy E-a was determined to be 11.2 and 12.2 kcal/mol (1 cal = 4.184 J) for cdMT1-MMP and DeltaTM-MT1-MMP respectively, which is consistent with k(cat)/K-M values of 7.37 and 1.46 x 10(4) M-1. s(-1). The k(cat)/K-M values for a series of similar single-stranded peptide substrates were determined and found to correlate with a slope of 0.17 for the two enzyme forms. A triple-helical peptide substrate was predicted to have a k(cat)/K-M of 0.87 x 10(4) M-1 . s(-1) for DeltaTM-MT1-MMP based on the value for cdMT1-MMP of 5.12 x 10(4) M-1. s(-1); however, the actual value was determined to be 2.5-fold higher, i.e. 2.18 x 10(4) M-1. s(-1). These results suggest that cdMT1-MMP is catalytically more efficient towards small peptide substrates than ATM-MT1-MMP and the haernopexin domain of MT1-MMP facilitates the hydrolysis of triple-helical substrates. Diastereomeric inhibitor pairs were utilized to probe further binding similarities at the active site. Ratios of K-i values for the inhibitor pairs were found to correlate between the enzyme forms with a slope of 1.03, suggesting that the haernopexin domain does not significantly modify the enzyme active-site structure.
Stichworte
diastereomeric MMP inhibitors;
ecto-domain;
membrane type 1-matrix metalloproteinase;
(MT I -MMP);
substrate specificity;
activation energy;
catalytic domain
Erscheinungsjahr
2004
Zeitschriftentitel
BIOCHEMICAL JOURNAL
Band
377
Seite(n)
775-779
ISSN
0264-6021
Page URI
https://pub.uni-bielefeld.de/record/1608728
Zitieren
Hurst DR, Schwartz MA, Ghaffari MA, et al. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. BIOCHEMICAL JOURNAL. 2004;377:775-779.
Hurst, D. R., Schwartz, M. A., Ghaffari, M. A., Jin, Y. H., Tschesche, H., Fields, G. B., & Sang, Q. X. A. (2004). Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. BIOCHEMICAL JOURNAL, 377, 775-779. https://doi.org/10.1042/bj20031067
Hurst, DR, Schwartz, MA, Ghaffari, MA, Jin, YH, Tschesche, Harald, Fields, GB, and Sang, QXA. 2004. “Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities”. BIOCHEMICAL JOURNAL 377: 775-779.
Hurst, D. R., Schwartz, M. A., Ghaffari, M. A., Jin, Y. H., Tschesche, H., Fields, G. B., and Sang, Q. X. A. (2004). Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. BIOCHEMICAL JOURNAL 377, 775-779.
Hurst, D.R., et al., 2004. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. BIOCHEMICAL JOURNAL, 377, p 775-779.
D.R. Hurst, et al., “Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities”, BIOCHEMICAL JOURNAL, vol. 377, 2004, pp. 775-779.
Hurst, D.R., Schwartz, M.A., Ghaffari, M.A., Jin, Y.H., Tschesche, H., Fields, G.B., Sang, Q.X.A.: Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. BIOCHEMICAL JOURNAL. 377, 775-779 (2004).
Hurst, DR, Schwartz, MA, Ghaffari, MA, Jin, YH, Tschesche, Harald, Fields, GB, and Sang, QXA. “Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities”. BIOCHEMICAL JOURNAL 377 (2004): 775-779.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
23 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity.
Sakr M, Li XY, Sabeh F, Feinberg TY, Tesmer JJG, Tang Y, Weiss SJ., J Biol Chem 293(21), 2018
PMID: 29643184
Sakr M, Li XY, Sabeh F, Feinberg TY, Tesmer JJG, Tang Y, Weiss SJ., J Biol Chem 293(21), 2018
PMID: 29643184
A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis.
Bosco DB, Roycik MD, Jin Y, Schwartz MA, Lively TJ, Zorio DA, Sang QA., PLoS One 12(2), 2017
PMID: 28234995
Bosco DB, Roycik MD, Jin Y, Schwartz MA, Lively TJ, Zorio DA, Sang QA., PLoS One 12(2), 2017
PMID: 28234995
Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity.
Cerofolini L, Amar S, Lauer JL, Martelli T, Fragai M, Luchinat C, Fields GB., Sci Rep 6(), 2016
PMID: 27405411
Cerofolini L, Amar S, Lauer JL, Martelli T, Fragai M, Luchinat C, Fields GB., Sci Rep 6(), 2016
PMID: 27405411
Rapid lead discovery through iterative screening of one bead one compound libraries.
Gao Y, Amar S, Pahwa S, Fields G, Kodadek T., ACS Comb Sci 17(1), 2015
PMID: 25434974
Gao Y, Amar S, Pahwa S, Fields G, Kodadek T., ACS Comb Sci 17(1), 2015
PMID: 25434974
Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
Stawikowski MJ, Stawikowska R, Fields GB., Biochemistry 54(19), 2015
PMID: 25897652
Stawikowski MJ, Stawikowska R, Fields GB., Biochemistry 54(19), 2015
PMID: 25897652
Development of a Förster resonance energy transfer assay for monitoring bacterial collagenase triple-helical peptidase activity.
Tokmina-Roszyk M, Tokmina-Roszyk D, Bhowmick M, Fields GB., Anal Biochem 453(), 2014
PMID: 24608089
Tokmina-Roszyk M, Tokmina-Roszyk D, Bhowmick M, Fields GB., Anal Biochem 453(), 2014
PMID: 24608089
Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.
Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX., J Med Chem 56(11), 2013
PMID: 23631440
Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX., J Med Chem 56(11), 2013
PMID: 23631440
Structural basis for matrix metalloproteinase 1-catalyzed collagenolysis.
Bertini I, Fragai M, Luchinat C, Melikian M, Toccafondi M, Lauer JL, Fields GB., J Am Chem Soc 134(4), 2012
PMID: 22239621
Bertini I, Fragai M, Luchinat C, Melikian M, Toccafondi M, Lauer JL, Fields GB., J Am Chem Soc 134(4), 2012
PMID: 22239621
Regulation of matrix metalloproteinase activity in health and disease.
Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO., FEBS J 278(1), 2011
PMID: 21087458
Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO., FEBS J 278(1), 2011
PMID: 21087458
Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V, Basu R, Moore L, Fan D, Wang X, Jaworski DM, Oudit GY, Kassiri Z., Circulation 124(19), 2011
PMID: 21986284
Kandalam V, Basu R, Moore L, Fan D, Wang X, Jaworski DM, Oudit GY, Kassiri Z., Circulation 124(19), 2011
PMID: 21986284
The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.
Arnold LH, Butt LE, Prior SH, Read CM, Fields GB, Pickford AR., J Biol Chem 286(52), 2011
PMID: 22030392
Arnold LH, Butt LE, Prior SH, Read CM, Fields GB, Pickford AR., J Biol Chem 286(52), 2011
PMID: 22030392
Synthesis and biological applications of collagen-model triple-helical peptides.
Fields GB., Org Biomol Chem 8(6), 2010
PMID: 20204190
Fields GB., Org Biomol Chem 8(6), 2010
PMID: 20204190
Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.
Lauer-Fields JL, Chalmers MJ, Busby SA, Minond D, Griffin PR, Fields GB., J Biol Chem 284(36), 2009
PMID: 19574232
Lauer-Fields JL, Chalmers MJ, Busby SA, Minond D, Griffin PR, Fields GB., J Biol Chem 284(36), 2009
PMID: 19574232
Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology.
Yang JG, Shen YH, Hong Y, Jin FH, Zhao SH, Wang MC, Shi XJ, Fang XX., J Ethnopharmacol 117(2), 2008
PMID: 18342464
Yang JG, Shen YH, Hong Y, Jin FH, Zhao SH, Wang MC, Shi XJ, Fang XX., J Ethnopharmacol 117(2), 2008
PMID: 18342464
Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase.
Li XY, Ota I, Yana I, Sabeh F, Weiss SJ., Mol Biol Cell 19(8), 2008
PMID: 18495869
Li XY, Ota I, Yana I, Sabeh F, Weiss SJ., Mol Biol Cell 19(8), 2008
PMID: 18495869
Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
Lauer-Fields JL, Whitehead JK, Li S, Hammer RP, Brew K, Fields GB., J Biol Chem 283(29), 2008
PMID: 18499673
Lauer-Fields JL, Whitehead JK, Li S, Hammer RP, Brew K, Fields GB., J Biol Chem 283(29), 2008
PMID: 18499673
Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.
Gioia M, Monaco S, Fasciglione GF, Coletti A, Modesti A, Marini S, Coletta M., J Mol Biol 368(4), 2007
PMID: 17379243
Gioia M, Monaco S, Fasciglione GF, Coletti A, Modesti A, Marini S, Coletta M., J Mol Biol 368(4), 2007
PMID: 17379243
Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Moss ML, Fields GB., Biochemistry 46(12), 2007
PMID: 17338550
Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Moss ML, Fields GB., Biochemistry 46(12), 2007
PMID: 17338550
Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB., J Am Chem Soc 129(34), 2007
PMID: 17672455
Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB., J Am Chem Soc 129(34), 2007
PMID: 17672455
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR, Schwartz MA, Jin Y, Ghaffari MA, Kozarekar P, Cao J, Sang QX., Biochem J 392(pt 3), 2005
PMID: 16026329
Hurst DR, Schwartz MA, Jin Y, Ghaffari MA, Kozarekar P, Cao J, Sang QX., Biochem J 392(pt 3), 2005
PMID: 16026329
Development of a solid-phase assay for analysis of matrix metalloproteinase activity.
Lauer-Fields JL, Nagase H, Fields GB., J Biomol Tech 15(4), 2004
PMID: 15585827
Lauer-Fields JL, Nagase H, Fields GB., J Biomol Tech 15(4), 2004
PMID: 15585827
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI, Jin Y, Hurst DR, Monroe CA, Lee S, Schwartz MA, Sang QX., J Biol Chem 278(51), 2003
PMID: 14532275
Park HI, Jin Y, Hurst DR, Monroe CA, Lee S, Schwartz MA, Sang QX., J Biol Chem 278(51), 2003
PMID: 14532275
Using fluorogenic peptide substrates to assay matrix metalloproteinases.
Fields GB., Methods Mol Biol 151(), 2001
PMID: 11217324
Fields GB., Methods Mol Biol 151(), 2001
PMID: 11217324
25 References
Daten bereitgestellt von Europe PubMed Central.
The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A, Kolkenbrock H, Tschesche H., FEBS Lett. 397(2-3), 1996
PMID: 8955363
Lichte A, Kolkenbrock H, Tschesche H., FEBS Lett. 397(2-3), 1996
PMID: 8955363
Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
Pei D, Weiss SJ., J. Biol. Chem. 271(15), 1996
PMID: 8621565
Pei D, Weiss SJ., J. Biol. Chem. 271(15), 1996
PMID: 8621565
Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?
Murphy G, Knauper V., Matrix Biol. 15(8-9), 1997
PMID: 9138283
Murphy G, Knauper V., Matrix Biol. 15(8-9), 1997
PMID: 9138283
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H, Bauzon DE, Xu X, Tschesche H, Cao J, Sang QA., Mol. Carcinog. 22(2), 1998
PMID: 9655252
Li H, Bauzon DE, Xu X, Tschesche H, Cao J, Sang QA., Mol. Carcinog. 22(2), 1998
PMID: 9655252
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Lauer-Fields JL, Tuzinski KA, Shimokawa Ki, Nagase H, Fields GB., J. Biol. Chem. 275(18), 2000
PMID: 10788434
Lauer-Fields JL, Tuzinski KA, Shimokawa Ki, Nagase H, Fields GB., J. Biol. Chem. 275(18), 2000
PMID: 10788434
Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.
Yana I, Weiss SJ., Mol. Biol. Cell 11(7), 2000
PMID: 10888676
Yana I, Weiss SJ., Mol. Biol. Cell 11(7), 2000
PMID: 10888676
Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.
Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX., J. Biol. Chem. 275(27), 2000
PMID: 10801841
Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX., J. Biol. Chem. 275(27), 2000
PMID: 10801841
Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris.
Roderfeld M, Buttner FH, Bartnik E, Tschesche H., Protein Expr. Purif. 19(3), 2000
PMID: 10910727
Roderfeld M, Buttner FH, Bartnik E, Tschesche H., Protein Expr. Purif. 19(3), 2000
PMID: 10910727
New thiol and sulfodiimine metalloproteinase inhibitors and their effect on human microvascular endothelial cell growth.
Sang QX, Jia MC, Schwartz MA, Jaye MC, Kleinman HK, Ghaffari MA, Luo YL., Biochem. Biophys. Res. Commun. 274(3), 2000
PMID: 10924354
Sang QX, Jia MC, Schwartz MA, Jaye MC, Kleinman HK, Ghaffari MA, Luo YL., Biochem. Biophys. Res. Commun. 274(3), 2000
PMID: 10924354
Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL, Broder T, Sritharan T, Chung L, Nagase H, Fields GB., Biochemistry 40(19), 2001
PMID: 11341845
Lauer-Fields JL, Broder T, Sritharan T, Chung L, Nagase H, Fields GB., Biochemistry 40(19), 2001
PMID: 11341845
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M., EMBO J. 20(17), 2001
PMID: 11532942
Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M., EMBO J. 20(17), 2001
PMID: 11532942
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley LJ, Matrisian LM., Curr. Opin. Cell Biol. 13(5), 2001
PMID: 11544020
McCawley LJ, Matrisian LM., Curr. Opin. Cell Biol. 13(5), 2001
PMID: 11544020
How matrix metalloproteinases regulate cell behavior.
Sternlicht MD, Werb Z., Annu. Rev. Cell Dev. Biol. 17(), 2001
PMID: 11687497
Sternlicht MD, Werb Z., Annu. Rev. Cell Dev. Biol. 17(), 2001
PMID: 11687497
Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
Lehti K, Lohi J, Juntunen MM, Pei D, Keski-Oja J., J. Biol. Chem. 277(10), 2002
PMID: 11779859
Lehti K, Lohi J, Juntunen MM, Pei D, Keski-Oja J., J. Biol. Chem. 277(10), 2002
PMID: 11779859
CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M., EMBO J. 21(15), 2002
PMID: 12145196
Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M., EMBO J. 21(15), 2002
PMID: 12145196
Matrix metalloproteinases and collagen catabolism.
Lauer-Fields JL, Juska D, Fields GB., Biopolymers 66(1), 2002
PMID: 12228918
Lauer-Fields JL, Juska D, Fields GB., Biopolymers 66(1), 2002
PMID: 12228918
Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
Park HI, Turk BE, Gerkema FE, Cantley LC, Sang QX., J. Biol. Chem. 277(38), 2002
PMID: 12119297
Park HI, Turk BE, Gerkema FE, Cantley LC, Sang QX., J. Biol. Chem. 277(38), 2002
PMID: 12119297
Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
Overall CM., Mol. Biotechnol. 22(1), 2002
PMID: 12353914
Overall CM., Mol. Biotechnol. 22(1), 2002
PMID: 12353914
Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Tam EM, Wu YI, Butler GS, Stack MS, Overall CM., J. Biol. Chem. 277(41), 2002
PMID: 12145314
Tam EM, Wu YI, Butler GS, Stack MS, Overall CM., J. Biol. Chem. 277(41), 2002
PMID: 12145314
Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.
Morrison JF., Biochim. Biophys. Acta 185(2), 1969
PMID: 4980133
Morrison JF., Biochim. Biophys. Acta 185(2), 1969
PMID: 4980133
Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination.
Riddles PW, Blakeley RL, Zerner B., Anal. Biochem. 94(1), 1979
PMID: 37780
Riddles PW, Blakeley RL, Zerner B., Anal. Biochem. 94(1), 1979
PMID: 37780
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Biochemical characterization of human collagenase-3.
Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G., J. Biol. Chem. 271(3), 1996
PMID: 8576151
Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G., J. Biol. Chem. 271(3), 1996
PMID: 8576151
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 14533979
PubMed | Europe PMC
Suchen in